Paul V Suenderh is categorized under Physical Medicine, Physician/Surgeon in Bala Cynwyd, PA and active since 2010.
Paul V Suenderh was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Physical Medicine, Physician/Surgeon business, which does work in the B2C market, and is classified as a Physical Medicine, Physician/Surgeon, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Paul V Suenderh at the company’s single location by writing to 555 East City Line Avenue, Bala Cynwyd, Pennsylvania PA 19004 or by phoning (610) 667-0100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Paul V Suenderh |
| Contact Person: | Paul V Suenderh |
| Address: | 555 East City Line Avenue, Bala Cynwyd, Pennsylvania 19004 |
| Phone Number: | (610) 667-0100 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physical Medicine, Physician/Surgeon |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Paul V Suenderh was started in 2010 to provide professional Physical Medicine, Physician/Surgeon under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Paul V Suenderh for inquiries that concern Paul V Suenderh by calling the company number (610) 667-0100, as your correspondence is most welcome. Additionally, the physical location of the single location of Paul V Suenderh can be found at the coordinates 40.008368,-75.211445 as well as the street address 555 East City Line Avenue in Bala Cynwyd, Pennsylvania 19004.
For its online presence, you may visit Paul V Suenderh’s website at and engage with its social media outlets through on Twitter and on Facebook.